Angiomyolipoma rebound tumor growth after discontinuation of everolimus in patients with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis.
John J BisslerNorio NonomuraKlemens BuddeBernard A ZonnenbergMichael FischerederMaurizio VoiAnne-Laure LouveauFabian HerbstE Martina BebinPaolo CuratoloAndrea ZontaElena BelousovaPublished in: PloS one (2018)
ClinicalTrials.gov NCT00790400.